Our prediction algorithm will therefore provide a valuable tool to bioinformaticians, molecular pathologists and clinicians to get an initial idea of the potential biochemical class of the detected mutation and to issue a therapy suggestion for patients presenting with new uncharacterized BRAF gene mutations in their tumor specimens. Here, BRAF is linked to neoplasm.